Calcium Influx Factor
Calcium Influx Factor
批准号:
7903957
负责人:
Victoria M Bolotina
金额:
$21.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-14 至 2011-07-31
关键词:
AchievementArtsAttentionBindingBiochemical PathwayBiological AssayBiological TestingBlood VesselsCalciumCalmodulinCationsCell membraneCellsChemicalsCollaborationsComplexDataDiseaseEndoplasmic ReticulumEnzymesFelis catusGoalsHealthHomeostasisHumanKnowledgeLaboratoriesLifeLysophospholipidsMass Spectrum AnalysisMembraneMethodsMolecularMolecular StructurePathway interactionsPhospholipase A2PhysiologicalPlatelet Factor 4ProductionRecording of previous eventsResearchResearch PersonnelRoleSTIM1 geneSamplingSecond Messenger SystemsSignal TransductionSourceStructureSystemTechniquesTestingUnited States National Institutes of HealthWorkYeastsanalogcell typeexperienceinnovationnovelnovel strategiesprogramspublic health relevancesecond messengersensortool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long term goal of the PI's laboratory is to define the molecular components and mechanism of the store- operated Ca2+ entry (SOCE), which is known to be activated upon depletion of intracellular Ca2+ stores in excitable and non-excitable cells The focus of this innovative proposal is on calcium influx factor (CIF), a notoriously elusive and still un- identified messenger, that is produced upon depletion of the stores and was found in all living cells tested so far (from yeast to humans). We have unique knowledge and extensive experience in working with CIF extracts. We had discovered the physiological target for CIF (a specific plasma membrane bound Ca2+ independent phospholipase A2), and demonstrated its crucial role in SOCE, which was confirmed by other investigators. Most recently, we identified STIM1 as a trigger for CIF production in the endoplasmic reticulum. During our previous studies that focused on the mechanism of CIF production, action and its role in SOCE pathway, PI's laboratory had accumulated unique knowledge and expertise that may finally allow molecular identification of this extremely important but still elusive messenger. We had established new methods for advanced multi-step purification and biological testing of CIF, and can obtain sufficient quantities of CIF of the highest purity that is essential for its instrumental analysis. The goal of our new proposal is molecular identification of CIF. We understand that this is an ambitious goal, but we believe that we finally have everything for its successful achievement: 1) the knowledge about the molecular trigger of CIF production, and about physiological target of CIF, 2) extensive experience in working with CIF extracts, 3) new abundant source of CIF, 4) all the tools and novel approaches for its fine purification, 5) new effective and sensitive bioassay approaches and methods for testing samples and candidate molecules for CIF activity, 6) state-of-the-art facilities and established collaborations with the world class experts in mass spectrometry, NMR and SOCE mechanism. The feasibility of CIF purification and identification of its molecular structure is fully supported by our unique expertise, and extensive preliminary data. Specific Aim of this proposal is to identify CIF. We will: 1.1. Determine chemical and structural components of CIF using advanced mass spectrometry and NMR techniques. 1.2. Synthesize CIF molecule and its inactive analogs. 1.3. Verify CIF identity in bioassay systems, and match it with endogenous CIF activity. 1.4. Identify the biochemical pathway for CIF production. PUBLIC HEALTH RELEVANCE: The goal of this proposal is to identify calcium influx factor (CIF), a novel second messenger that is ubiquitously produced by all the cell types tested so far (from yeast to human), and is involved in activation of the store-operated Ca2+ entry pathway, one of the major mechanisms that determine Ca2+ homeostasis in health and disease. The feasibility of CIF identification is fully supported by our unique expertise, extensive preliminary data and advanced approaches that are already developed in PI's lab.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PARK14/Calcium signaling as a novel biomarker for Parkinson disease
-
批准号:9379694
-
项目类别:
-
资助金额:$25.33万
-
财政年份:2017
-
负责人:Victoria M Bolotina
-
依托单位:
Calcium Influx Factor
-
批准号:7752223
-
项目类别:
-
资助金额:$25.28万
-
财政年份:2009
-
负责人:Victoria M Bolotina
-
依托单位:
Conference Proposal: Ion Channel Regulation
-
批准号:7278506
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2007
-
负责人:Victoria M Bolotina
-
依托单位:
Store-Operated Ca entry and iPLA2 in vascular SMC
-
批准号:7584587
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2003
-
负责人:Victoria M Bolotina
-
依托单位:
Store-operated Ca2+ influx & iPLA2 in vascular SMC
-
批准号:6893652
-
项目类别:
-
资助金额:$60.38万
-
财政年份:2003
-
负责人:Victoria M Bolotina
-
依托单位:
Store-Operated Ca entry and iPLA2 in vascular SMC
-
批准号:8207925
-
项目类别:
-
资助金额:$41.83万
-
财政年份:2003
-
负责人:Victoria M Bolotina
-
依托单位:
Store-Operated Ca entry and iPLA2 in vascular SMC
-
批准号:7996611
-
项目类别:
-
资助金额:$42.25万
-
财政年份:2003
-
负责人:Victoria M Bolotina
-
依托单位:
Store-operated Ca2+ influx & iPLA2 in vascular SMC
-
批准号:6679543
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2003
-
负责人:Victoria M Bolotina
-
依托单位:
Store-operated Ca2+ influx & iPLA2 in vascular SMC
-
批准号:7067126
-
项目类别:
-
资助金额:$58.96万
-
财政年份:2003
-
负责人:Victoria M Bolotina
-
依托单位:
Store-Operated Ca entry and iPLA2 in vascular SMC
-
批准号:7741705
-
项目类别:
-
资助金额:$42.25万
-
财政年份:2003
-
负责人:Victoria M Bolotina
-
依托单位:
Store-operated Ca2+ influx & iPLA2 in vascular SMC
-
批准号:6759324
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2003
-
负责人:Victoria M Bolotina
-
依托单位:
Identification of Calcium Influx Factor (suppl. to RO1)
-
批准号:6825907
-
项目类别:
-
资助金额:$20.13万
-
财政年份:2002
-
负责人:Victoria M Bolotina
-
依托单位:
NITRIC OXIDE AND ION CHANNELS IN VASCULAR SMOOTH MUSCLE
-
批准号:2750468
-
项目类别:
-
资助金额:$27.32万
-
财政年份:1996
-
负责人:Victoria M Bolotina
-
依托单位:
NITRIC OXIDE AND ION CHANNELS IN VASCULAR SMOOTH MUSCLE
-
批准号:2232411
-
项目类别:
-
资助金额:$25.39万
-
财政年份:1996
-
负责人:Victoria M Bolotina
-
依托单位:
Ion Channels, calcium regulation and nitric oxide in vsm
-
批准号:6543902
-
项目类别:
-
资助金额:$14.58万
-
财政年份:1996
-
负责人:Victoria M Bolotina
-
依托单位:
ION CHANNELS, CALCIUM AND NITRIC OXIDE IN VSM
-
批准号:6611381
-
项目类别:
-
资助金额:$39.64万
-
财政年份:1996
-
负责人:Victoria M Bolotina
-
依托单位:
ION CHANNELS, CALCIUM AND NITRIC OXIDE IN VSM
-
批准号:6263104
-
项目类别:
-
资助金额:$30.06万
-
财政年份:1996
-
负责人:Victoria M Bolotina
-
依托单位:
ION CHANNELS, CALCIUM AND NITRIC OXIDE IN VSM
-
批准号:6527057
-
项目类别:
-
资助金额:$27.56万
-
财政年份:1996
-
负责人:Victoria M Bolotina
-
依托单位:
Ion channels and calcium regulation in vascular SMC function
-
批准号:8043606
-
项目类别:
-
资助金额:$43.15万
-
财政年份:1996
-
负责人:Victoria M Bolotina
-
依托单位:
Ion channels and Ca regulation in vascular SMC function
-
批准号:7102636
-
项目类别:
-
资助金额:$39.3万
-
财政年份:1996
-
负责人:Victoria M Bolotina
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Handbook of the Mathematics of the Arts and Sciences的中文翻译
-
批准号:12226504
-
项目类别:数学天元基金项目
-
资助金额:20.0万元
-
批准年份:2022
-
负责人:黄朝凌
-
依托单位:
ARTS在邻苯二甲酸(2-乙基己基)酯诱导的小鼠睾丸间质细胞凋亡中的作用及机理研究
-
批准号:--
-
项目类别:--
-
资助金额:35万元
-
批准年份:2020
-
负责人:陈加祥
-
依托单位:
ARTS在邻苯二甲酸(2-乙基己基)酯诱导的小鼠睾丸间质细胞凋亡中的作用及机理研究
-
批准号:82060278
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2020
-
负责人:陈加祥
-
依托单位:
促进肿瘤凋亡的融合蛋白CPP-TRAIL-ARTS C27的制备及机制研究
-
批准号:81372444
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:易成
-
依托单位:
雄性锹甲的生殖对策抉择ARTs及其进化机制-基于行为与SSRs标记的整合研究
-
批准号:31201745
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2012
-
负责人:万霞
-
依托单位: